| [1] |
GRAUS F, VOGRIG A, MUÑIZ-CASTRILLO S, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes[J]. Neurol Neuroimmunol Neuroinflamm, 2021, 8(4): e1014. doi: 10.1212/NXI.0000000000001014
|
| [2] |
GRAUS F, DALMAU J. Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors[J]. Nat Rev Clin Oncol, 2019, 16(9): 535-548. doi: 10.1038/s41571-019-0194-4
|
| [3] |
林敬, 何妮. 抗amphiphysin和抗水通道蛋白4双抗体阳性神经系统副肿瘤综合征并重症肌无力一例[J]. 华西医学, 2020, 35(6): 750-752. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYX202006024.htm
|
| [4] |
KWATRA V, CHARAKIDIS M, KARANTH N V. Bilateral facial nerve palsy associated with amphiphysin antibody in metastatic breast cancer: A case report[J]. J Med Case Rep, 2021, 15(1): 158. doi: 10.1186/s13256-021-02727-3
|
| [5] |
DÉCHELOTTE B, MŪNIZ-CASTRILLO S, JOUBERT B, et al. Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(3): e701. doi: 10.1212/NXI.0000000000000701
|
| [6] |
RIO R, SPAGNI G, MASI G. Paraneoplastic neurological syndromes[J]. Semin Diagn Pathol, 2019, 36(4): 279-292. doi: 10.1053/j.semdp.2019.06.005
|
| [7] |
OLIVEIRA V, VIDEIRA G, SAMÕES R, et al. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study[J]. J Neurol Sci, 2020, 418: 117103. doi: 10.1016/j.jns.2020.117103
|
| [8] |
HÉBERT J, RICHE B, VOGRIG A, et al. Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(6): e883. doi: 10.1212/NXI.0000000000000883
|
| [9] |
CEYHUM S, HVLYA T, ERDEM T, et al. Determination of Paraneoplastic neuropathy in newly diagnosed breast tumor patients[J]. eNeurologicalSci, 2020, 21: 100265. doi: 10.1016/j.ensci.2020.100265
|
| [10] |
TANNOURY J, DE MESTIER L, HENTIC O, et al. Contribution of immune-mediated paraneoplastic syndromes to neurological manifestations of neuroendocrine tumours: A retrospective study[J]. Neuroendocrinology, 2021, 111(1-2): 123-128. doi: 10.1159/000506400
|
| [11] |
BERZERO G, KARANTONI E, DEHAIS C, et al. Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies[J]. Neurol Neurosurg Psychiatry, 2018, 89(7): 789-792. doi: 10.1136/jnnp-2017-316904
|
| [12] |
NISHIJIMA H, ONODERA K, SATO N, et al. Subacute sensory ataxic neuronopathy with thymoma presenting marked improvement after steroid therapy[J]. Front Neurol, 2019, 10: 268. doi: 10.3389/fneur.2019.00268
|
| [13] |
荣玉婷, 余锋, 许力. 17例神经系统副肿瘤综合征临床分析[J]. 中华全科医学, 2020, 18(6): 902-905. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202006006.htm
|
| [14] |
KHANAM R, FANOUS IS, FADHEL EN, et al. Voltage-gated calcium channel antibody-induced oropharyngeal dysphagia presenting as a paraneoplastic neurological complication in breast cancer[J]. Cureus, 2021, 13(3): e13677.
|
Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com
Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2
Supported by:
Beijing Renhe Information Technology Co., Ltd.
DownLoad: